Harvard Medical School, New Research Building, Room 350, 77 Avenue Louis Pasteur, Boston, MA
Celixir plc is a UK stem cell company with two Phase 3 products, and is expected to IPO in 2018 with the founders still retaining 75% of the equity (after 5 rounds of external funding).
Founders Prof. Sir Martin Evans (2007 Nobel Laureate) and CEO Ajan Reginald (Former Global Head of New Technologies, Roche Pharmaceuticals),...
Celixir plc is a UK stem cell company with two Phase 3 products, and is expected to IPO in 2018 with the founders still retaining 75% of the equity (after 5 rounds of external funding).
Founders Prof. Sir Martin Evans (2007 Nobel Laureate) and CEO Ajan Reginald (Former Global Head of New Technologies, Roche...
Dana-Farber Cancer Institute, Jimmy Fund Auditorium, 35 Binney Street, Boston, MA
Dana-Farber Cancer Institute Seminars in Oncology
Guest speaker: Eric Holland, MD, PhD Sr. VP and Director, Human Biology Division Fred Hutchinson Cancer Research Center and UW Medicine University of Washington
Harvard Medical School, New Research Building, Room 1031, 77 Avenue Louis Pasteur, Boston, MA
Nanocourse of the Genetics Department
Lecturers: Ali Rudolph, Kelsey Tyssowski, Katherine Wu
In the era of fake news and alternative facts, communicating science clearly and effectively to the general public is more important than ever. From tweets to Facebook posts to news articles, there are countless media through which we can bring science to people from all walks of life. This nanocourse offers the opportunity to learn the basics of science writing for general audiences through...